BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15361646)

  • 1. Local recurrence of rectal cancer after total mesorectal excision without preoperative radiotherapy.
    van Lingen CP; Zeebregts CJ; Gerritsen JJ; Mulder HJ; Mastboom WJ; Klaase JM
    Int J Gastrointest Cancer; 2003; 34(2-3):129-34. PubMed ID: 15361646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
    Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
    Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative surgery for local pelvic recurrence of rectal cancer.
    Saito N; Koda K; Takiguchi N; Oda K; Ono M; Sugito M; Kawashima K; Ito M
    Dig Surg; 2003; 20(3):192-9; discussion 200. PubMed ID: 12759498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
    Zhan T; Gu J; Li M; Du C
    Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative staging of rectal cancer allows selection of patients for preoperative radiotherapy.
    Horgan AF; Finlay IG
    Br J Surg; 2000 May; 87(5):575-9. PubMed ID: 10792312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
    Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
    Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
    Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
    Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low rates of local recurrence after surgical resection of rectal cancer suggest a selective policy for preoperative radiotherapy.
    Senapati A; O'Leary DP; Flashman KG; Parvaiz A; Thompson MR
    Colorectal Dis; 2012 Jul; 14(7):838-43. PubMed ID: 21920008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is pre-operative radiotherapy necessary in T-T rectal cancer with TME?
    Mackay G; Downey M; Molloy RG; O'Dwyer PJ
    Colorectal Dis; 2006 Jan; 8(1):34-6. PubMed ID: 16519635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative radiotherapy combined with intraoperative radiotherapy improve results of total mesorectal excision in patients with T3 rectal cancer.
    Pacelli F; Di Giorgio A; Papa V; Tortorelli AP; Covino M; Ratto C; Bossola M; Valentini V; Sofo L; Miccichè F; Gambacorta MA; Doglietto GB
    Dis Colon Rectum; 2004 Feb; 47(2):170-9. PubMed ID: 15043286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision?
    Suh KW; Kim BW; Chun M; Lim HY
    Hepatogastroenterology; 2002; 49(44):399-403. PubMed ID: 11995460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.
    van Gijn W; van Stiphout RGPM; van de Velde CJH; Valentini V; Lammering G; Gambacorta MA; Påhlman L; Bujko K; Lambin P
    Ann Oncol; 2015 May; 26(5):928-935. PubMed ID: 25609247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal cancer: local recurrence after surgery without radiotherapy.
    Bonadeo FA; Vaccaro CA; Benati ML; Quintana GM; Garione XE; Telenta MT
    Dis Colon Rectum; 2001 Mar; 44(3):374-9. PubMed ID: 11289283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance in rectal cancer treatment.
    van de Velde CJ; van den Broek CB
    Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
    Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
    Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study.
    Räsänen M; Renkonen-Sinisalo L; Mustonen H; Lepistö A
    World J Surg Oncol; 2019 Aug; 17(1):139. PubMed ID: 31395058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.